BETA — Beta Drugs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹13.96bn
- IN₹14.03bn
- IN₹3.85bn
Annual cashflow statement for Beta Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 343 | 411 | 488 | 615 | 544 |
| Depreciation | |||||
| Non-Cash Items | -21.6 | -83.9 | -140 | -189 | -72.7 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -97.7 | -197 | -136 | -190 | -270 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 296 | 234 | 309 | 361 | 373 |
| Capital Expenditures | -194 | -182 | -116 | -369 | -535 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -23.3 | -8.57 | -23.6 | 11.4 | 20.9 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -218 | -191 | -140 | -357 | -514 |
| Financing Cash Flow Items | -28 | -24.1 | -28.2 | -69.9 | -84.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9.73 | -24.7 | -74.9 | 1,180 | -80.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 69 | 18.4 | 94.7 | 1,184 | -222 |